Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,070 | -12,618 | -129,814 | -56,953 | -38,078 |
| Depreciation Amortization | 7,309 | 3,503 | 10,495 | 6,898 | 3,834 |
| Accounts payable and accrued liabilities | 2,422 | 1,629 | 1,064 | 4,335 | 3,775 |
| Other Working Capital | 1,176 | 2,564 | 2,342 | 4,413 | 6,273 |
| Other Operating Activity | -1,348 | -1,187 | 92,348 | 33,904 | 34,408 |
| Operating Cash Flow | $-15,511 | $-6,109 | $-23,565 | $-7,403 | $10,212 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -141,440 | 54,049 | 167,951 | 68,178 | 121,916 |
| PPE Investments | -58,877 | -33,222 | -90,518 | -59,027 | -35,762 |
| Net Acquisitions | N/A | N/A | 2,453 | 2,453 | 2,453 |
| Sale Of Investment | N/A | N/A | -20,822 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -80,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -80,000 | 0 | 0 |
| Investing Cash Flow | $-200,317 | $20,827 | $-20,936 | $11,604 | $88,607 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 250,000 | 250,000 | N/A |
| Debt Repayment | -753 | -386 | -155,571 | -1,041 | -447 |
| Common Stock Issued | 11,900 | 2,493 | 4,110 | 2,449 | 2,062 |
| Financing Cash Flow | $11,147 | $2,107 | $98,539 | $251,408 | $1,615 |
| Beginning Cash Position | 341,768 | 341,768 | 287,730 | 287,730 | 287,730 |
| End Cash Position | 137,087 | 358,593 | 341,768 | 543,339 | 388,164 |
| Net Cash Flow | $-204,681 | $16,825 | $54,038 | $255,609 | $100,434 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,511 | -6,109 | -23,565 | -7,403 | 10,212 |
| Capital Expenditure | -58,877 | -33,222 | -90,518 | -59,027 | -35,762 |
| Free Cash Flow | -74,388 | -39,331 | -114,083 | -66,430 | -25,550 |